Steven Cohen Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $2.35 Million - $3.36 Million	-36,608 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $2.38 Million - $3.6 Million	36,608 New	36,608 $3.14 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $12.5 Million - $26.1 Million	-454,989 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $18.6 Million - $26.2 Million	454,989 New	454,989 $24.8 Million
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $2.23 Million - $3.22 Million	-75,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $2.46 Million - $3.23 Million	75,000 New	75,000 $2.82 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.36B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.